Your browser doesn't support javascript.
loading
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson, A G; Appleton, R; Baker, G A; Chadwick, D W; Doughty, J; Eaton, B; Gamble, C; Jacoby, A; Shackley, P; Smith, D F; Tudur-Smith, C; Vanoli, A; Williamson, P R.
Affiliation
  • Marson AG; Division of Neurological Science, University of Liverpool, UK.
Health Technol Assess ; 11(37): iii-iv, ix-x, 1-134, 2007 Oct.
Article in En | MEDLINE | ID: mdl-17903391
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Treatment Outcome / Epilepsy / Anticonvulsants Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male Language: En Journal: Health Technol Assess Journal subject: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Year: 2007 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Treatment Outcome / Epilepsy / Anticonvulsants Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male Language: En Journal: Health Technol Assess Journal subject: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Year: 2007 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom